Retrieval of Patient Information After Discontinuation

NCT01658722 · clinicaltrials.gov ↗

TERMINATED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Bapineuzumab

Sponsor

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Collaborators

[object Object]